Smart Telehealth Exercise Intervention to Reduce COPD Readmissions
Completed · Not applicable
Conditions studied: Chronic Obstructive Pulmonary Disease
In brief
This is a prospective randomized controlled study to test the hypothesis that neuromuscular electrical stimulation (NMES) and remote pulmonary rehabilitation at home offered via a smart technology, called Smart TeleHealth, results in a reduction of systemic inflammation, via reduction of skeletal muscle tissue inflammation, and thereby improves functional capacity, and thus, reduces the rate of readmissions following hospitalization for acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD). This study will enroll up to 40 participants at the University of Alabama at Birmingham (UAB), about 30 will get Smart Telehealth and NMES, and 10 will get usual care.
Key facts
- Study ID
- NCT03089853
- Run by
- University of Alabama at Birmingham
- People needed
- 7
- Starts
- 2016-07-14
- Expected to finish
- 2020-08-15
- Last updated by the study team
- 2022-03-22
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects who are hospitalized with an acute exacerbation of COPD and can be enrolled within 36 hours of hospitalization.
- Age 40 years or older.
You may not qualify if…
- Secondary diagnosis of congestive heart failure and other respiratory conditions that could confound the diagnosis such as pneumonia, bronchiectasis and lung cancer will be excluded.
- Those on invasive or mechanical ventilation will not be enrolled.
- Participants with pacemakers/defibrillators will not be enrolled due to concern for interaction with NEMS.
- Inability to consent for themselves.
- Pregnant or breastfeeding women will be excluded to minimize the risks of neuromuscular electrical stimulation.
Where it is running
- UAB Lung Health Center — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.